Decreased E-cadherin augments β-catenin nuclear localization:: Studies in breast cancer cell lines

被引:0
|
作者
Yang, SZ [1 ]
Kohno, N [1 ]
Yokoyama, A [1 ]
Kondo, K [1 ]
Hamada, H [1 ]
Hiwada, K [1 ]
机构
[1] Ehime Univ, Sch Med, Dept Internal Med 2, Matsuyama, Ehime 7910295, Japan
关键词
adenomatous polyposis coli; lymphocyte-enhancer factor; T-cell factor; antisense; c-myc;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We showed that the YMB-1-derived breast cancer cell line YMB-S, which proliferates in suspension without aggregation, exhibits complete loss of cell-cell adhesion despite the presence of E-cadherin-catenin complex and expression of free beta -catenin in the cytoplasm. Here, we describe beta -catenin gene regulation, interaction with E-cadherin, immunocytochemical localization, and their relation to growth rate in the YMB-1-derived cell line YMB-A, which forms tight junctions and displays anchorage-dependent growth. YMB-A cells proliferated more slowly than YMB-S cells. E-cadherin and APC gene product expression in YMB-A cells was significantly higher than that in YMB-S cells, whereas expression of beta -catenin, MUC1, and c-myc was lower in YMB-A cells than in YMB-S cells. According to immunocytochemical analysis, beta -catenin in YMB-A cells displayed membranous or submembranous localization, indicating that beta -catenin is mostly tethered to E-cadherin. Inhibition of E-cadherin expression in YMB-A cells by an antisense oligonucleotide did not change expression of whole eel beta -catenin protein, but increased nuclear beta -catenin protein level, c-myc expression, and cell growth rate. These results suggest that decreased expression of E-cadherin and APC and increased amount of beta -catenin in YMB-S cells lead to accumulation of beta -catenin in the nucleus, activate beta -catenin-LEF/TCF signaling pathway, and trigger c-myc proto-oncogene expression, c-Myc overexpression in breast cancer may be related to activated Wnt independent beta -catenin-LEF/TCF signaling.
引用
收藏
页码:541 / 548
页数:8
相关论文
共 50 条
  • [21] Alterations of E-cadherin and β-catenin in gastric cancer
    Chen Huiping
    Sigrun Kristjansdottir
    Jon G Jonasson
    Jonas Magnusson
    Valgardur Egilsson
    Sigurdur Ingvarsson
    BMC Cancer, 1
  • [22] CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of β-catenin and E-cadherin
    Yaowu He
    Claire M. Davies
    Brittney S. Harrington
    Linh Hellmers
    Yonghua Sheng
    Amy Broomfield
    Thomas McGann
    Kate Bastick
    Laurie Zhong
    Andy Wu
    Grace Maresh
    Shannon McChesney
    Kuan Yau Wong
    Mark N. Adams
    Ryan C. Sullivan
    James S. Palmer
    Lez J. Burke
    Adam D. Ewing
    Xin Zhang
    David Margolin
    Li Li
    Rohan Lourie
    Admire Matsika
    Bhuvana Srinivasan
    Michael A. McGuckin
    John W. Lumley
    John D. Hooper
    Oncogene, 2020, 39 : 219 - 233
  • [23] CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of β-catenin and E-cadherin
    He, Yaowu
    Davies, Claire M.
    Harrington, Brittney S.
    Hellmers, Linh
    Sheng, Yonghua
    Broomfield, Amy
    McGann, Thomas
    Bastick, Kate
    Zhong, Laurie
    Wu, Andy
    Maresh, Grace
    McChesney, Shannon
    Wong, Kuan Yau
    Adams, Mark N.
    Sullivan, Ryan C.
    Palmer, James S.
    Burke, Lez J.
    Ewing, Adam D.
    Zhang, Xin
    Margolin, David
    Li, Li
    Lourie, Rohan
    Matsika, Admire
    Srinivasan, Bhuvana
    McGuckin, Michael A.
    Lumley, John W.
    Hooper, John D.
    ONCOGENE, 2020, 39 (01) : 219 - 233
  • [24] E-cadherin and β-catenin expression in breast medullary carcinomas
    Charpin, C
    Bonnier, P
    Garcia, S
    Andrac, L
    Crebassa, B
    Dorel, M
    Lavaut, MN
    Allasia, C
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 15 (02) : 285 - 292
  • [25] E-cadherin mutations in human colorectal cancer cell lines
    Wheeler, J
    Efstathiou, JA
    Kim, HC
    Beck, NE
    Ilyas, M
    Mortensen, NJM
    Bodmer, WF
    GASTROENTEROLOGY, 1999, 116 (04) : A529 - A529
  • [26] E-cadherin mutations in human colorectal cancer cell lines
    Wheeler, JMD
    Efstathiou, JA
    Kim, HC
    Beck, NE
    Ilyas, M
    Mortensen, NJM
    Bodmer, WF
    GUT, 1999, 44 : A100 - A100
  • [27] E-cadherin & β-catenin expression in breast cancer:: Is there change of expression with progression of disease?
    Riding, MA
    Wencyk, PM
    Bell, JA
    Ellis, IO
    Elston, CW
    Pinder, SE
    JOURNAL OF PATHOLOGY, 2000, 192 : 19A - 19A
  • [28] Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer
    Pang, Hui
    Lu, Hailing
    Song, Hongtao
    Meng, Qingwei
    Zhao, Yanbin
    Liu, Na
    Lan, Fei
    Liu, Ying
    Yan, Suhong
    Dong, Xiaoqun
    Cai, Li
    CANCER EPIDEMIOLOGY, 2013, 37 (06) : 985 - 992
  • [29] REDUCED ALPHA-CATENIN AND E-CADHERIN EXPRESSION IN BREAST-CANCER
    RIMM, DL
    SINARD, JH
    MORROW, JS
    LABORATORY INVESTIGATION, 1995, 72 (05) : 506 - 512
  • [30] Immunohistochemical localization of E-cadherin, α and β catenin in salivary glands and their tumours
    Namba, M
    Yamada, K
    Kudeken, W
    Muramatu, Y
    Sumitomo, S
    Mori, M
    Takai, Y
    ORAL ONCOLOGY, VOL V, 1997, : 473 - 476